Skip to content
healthcare.dev

DG health mucus dm

NDC 55910-746, dextromethorphan hydrobromide, guaifenesin, tablet, extended release, from Dolgencorp Inc.

Product NDC
55910-746
Status
Listed
Labeler
Dolgencorp Inc
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA207602
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55910-746 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROMETHORPHAN HYDROBROMIDE30 mg/1
  • GUAIFENESIN600 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
55910-746-01559100746011 BOTTLE in 1 CARTON (55910-746-01) / 20 TABLET, EXTENDED RELEASE in 1 BOTTLE
55910-746-91559100746916 BLISTER PACK in 1 CARTON (55910-746-91) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55910-746 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55910-746 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55910-746. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.